Vivian DeWoskin is the Chief Commercial Officer at NeuraLight, where she oversees all aspects of commercial development of NeuraLight's digital biomarker and diagnostics platform. Prior to joining NeuraLight, Vivian held multiple leadership roles at Komodo Health, where she led teams responsible for market strategy, product development, and go-to-market initiatives. Before Komodo Health, Vivian spent nearly a decade in life sciences strategy consulting at Trinity Life Sciences, focusing on helping pharma and biotech clients launch novel, innovative therapeutics to the market. Vivian holds a BA in Psychology & Neuroscience from Princeton University, and an MBA from Berkeley Haas.